Skip to content

Effectiveness of a Structured Intervention to Reduce the Progression of Chronic Kidney (RENAP Study)

Effectiveness of an Structured Intervention in Patients With Chronic Kidney Failure to Reduce the Progression of the Illness.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01872468
Acronym
RENAP
Enrollment
269
Registered
2013-06-07
Start date
2011-09-30
Completion date
2014-01-31
Last updated
2015-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Insufficiency Chronic

Keywords

Glomerular filtration Rate., Primary Health Care., Cluster Clinical Trial.

Brief summary

The propose of study is to study if an informative intervention and a structured follow-up carried out in health centres of primary care in patients with chronic kidney failure, stage 3, is more effective than the current follow-up in slowing the disease progression measured by the glomerular filtration rate.

Detailed description

Main objective: To study if an informative intervention and a structured follow-up carried out in health centres of primary care in patients with chronic kidney failure, stages 3, is more effective than the current follow-up in slowing the disease progression measured by the glomerular filtration rate . Secondary objectives: Determining the effectiveness of the intervention to improve the blood pressure control of the patients with chronic kidney failure and to improve the degree of control of the glucose levels and glycosylated haemoglobin of the diabetic patients with chronic kidney failure. Design: A clinical trial controlled with a random assignment by conglomerates with parallel groups. Setting: Multi-centre study in Primary Care Health Centres(Madrid Health Service). Subjects of the study: 540 patients over 18 years old, diagnosed of light-moderate chronic kidney failure that consent to participate. Data collection: The variable of the main answer will be the creatinine clearance measured in ml/min. Demographic variables of morbidity and prognosis: clinical, analytical, anthropometrical, adherence to processing and consumption of medicines will be collected. Intervention: Initial educational session based on the significant learning and quarterly follow-up in surgery of medicine and nursing for 2 years. Analysis: By intention of treating. Descriptive statistics of each variable and statistical analytical univariate and multivariate (multiple linear regression) will be carried out. The explanatory variable in the analysis multivariate will be the intervention group.

Interventions

Initial training session based on patient personal experiences and reflexion (30 minutes). CKD learning session (30 minutes). Personal plan of actions to cope with own disease (30 minutes. Discussion of doubts (30 minutes). Follow up visits every four months at physicians and nurses´ offices over a two-year period

Sponsors

Instituto de Salud Carlos III
CollaboratorOTHER_GOV
Gerencia de Atención Primaria, Madrid
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients 18 years of age or older * Willing and able to give informed consent for participation in the study. * Ability to understand study procedures and to comply with them for the entire length of the study. * Registered episode on electronic medical records in Primary Care with the diagnosis of Chronic Kidney Disease (CKD) stage 3 or confirmation of CKD by a second blood sample in risk patients with suspected CKD( owing to a blood sample taken at least three months before

Exclusion criteria

* Inability or unwillingness to give written informed consent. * Severe psychiatric conditions including depression and major affective disorders registered on medical records. * Disabled and unable to attend Health Centre. * Severe CKD, defined as glomerular filtration rate (GFR) \< 30 ml/min/1,73m2. * Patients undergoing dialysis or kidney transplantation. * Patients hemodynamically unstable with impaired kidney function (Eg. Cardiac Failure, unstable angina pectoris). * Acute kidney failure. * Patients with an episode of impaired kidney perfusion on the last month (Eg. Severe hemorrhage, burns, dehydration, major trauma).

Design outcomes

Primary

MeasureTime frameDescription
Creatinine clearance2 yearsGlomerular filtration rate measured by Modification of Diet in Renal Disease (MDRD)formula and expressed in ml/min. The MDRD formula estimates the glomerular filtrate through the levels of creatinine plasma, sex and age.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026